Trending
Company Overview

Tessera Therapeutics

Sector: Healthcare

Tessera Therapeutics is a biotechnology company developing gene writing technologies designed to insert therapeutic genetic payloads into the genome to treat disease.

We are tracking 1 layoff event for Tessera Therapeutics as of Dec 25, 2025.

Key Metrics
90
Total Employees Affected
1
Layoff Events
35%
Avg. Percentage
Layoff Timeline
Dec 2025
Layoff History
December 25, 2025

Tessera Therapeutics announced layoffs of 90 employees (approximately 35% of workforce) as part of pipeline prioritization. The Massachusetts-based biotech expects layoffs to begin March 8, 2026. No facilities will...

Other Layoffs